Editor’s note – Express Pharma

Can IPRs be part of the COVID-19 solution, rather than the problem?

Putting the vulnerable first could end the pandemic faster

The politics of pandemics

Navigating a COVIDitised world

Why drug repurposing needs first good science, then hope

Learning to live with COVID-19

Will the industry sell COVID-19 meds at the min production costs?

China’s recovery from COVID-19 should not tempt us to take the easy way out again

Lessons from COVID-19

2019-nCoV, nitrosamine issues trigger supply chain re-jigs